References

1. Jung D, Long-Boyle JR, Pang WW, Gobburu JVS. (2024) Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia. Transplant Cell Ther, 30 (9): 923.e1-923.e9. [PMID:38972509]

2. Wedi B. (2023) Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development. Expert Opin Investig Drugs, 32 (11): 1043-1054. [PMID:37897679]